Ind-Swift Laboratories schedules 31st AGM for September 30, 2026

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Ind-Swift Laboratories holds 31st AGM on September 30, 2026 via VC/OAVM
  • Annual report for FY26 submitted to BSE and NSE on September 5, 2026
  • Share transfer books closed from September 24 to September 30, 2026
  • Voting cut-off date fixed at September 23, 2026 per Companies Act rules
powered bylight_fuzz_icon
50174458

*this image is generated using AI for illustrative purposes only.

Ind-Swift Laboratories Limited will hold its 31st Annual General Meeting (AGM) on September 30, 2026. The event will be conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM) starting at 3:00 pm.

The company submitted its annual report for the financial year 2025-26 (FY26) to the stock exchanges. The filing was made in compliance with Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Dates and Procedures

The cut-off date for determining voting entitlement is September 23, 2026. This aligns with Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014.

Share transfer books will remain closed from September 24, 2026, to September 30, 2026. This closure facilitates the AGM process as mandated by regulatory guidelines.

Event Date Details
Cut-off date September 23, 2026 Voting entitlement determination
Book closure start September 24, 2026 Share transfer books closed
AGM date September 30, 2026 VC/OAVM mode at 3:00 pm
Book closure end September 30, 2026 Share transfer books reopen

Pardeep Verma, VP-Corporate Affairs & Company Secretary, signed the submission letter dated September 5, 2026. The notice includes procedures for remote e-voting before and during the meeting.

Historical Stock Returns for Ind Swift Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-4.49%-0.58%+55.69%+159.38%+247.03%+405.61%

What specific financial performance metrics or strategic initiatives are expected to be highlighted in the FY26 annual report?

How might the proposed dividend policy or capital allocation plans discussed at the AGM impact shareholder returns in the near term?

Are there any significant changes to the board of directors or executive management team anticipated during the September 30 meeting?

like16
dislike

Ind-Swift Laboratories fixes warrant issue price at ₹196

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Ind-Swift Laboratories fixes warrant issue price at ₹196 each
  • Regulatory floor price determined at ₹195.98 based on 10-day VWAP
  • Independent valuer estimated warrant value at ₹189.46
  • Price approved by Preferential Issue Committee on September 4, 2026
powered bylight_fuzz_icon
50064384

*this image is generated using AI for illustrative purposes only.

Ind-Swift Laboratories has fixed the issue price for its preferential allotment of warrants at ₹196 each. The Preferential Issue Committee approved the pricing during a meeting held on September 4, 2026, following shareholder approval at an Extra-Ordinary General Meeting on August 5, 2026.

The final issue price exceeds both the regulatory floor price and the independent valuation estimate. Under Regulation 164 of the SEBI ICDR Regulations, 2018, the minimum floor price was determined to be ₹195.98, based on the higher of the 90-day volume-weighted average price (₹154.48) and the 10-day volume-weighted average price (₹195.98) preceding the relevant date of July 6, 2026.

Pricing Methodology

The company followed a multi-step pricing framework mandated by SEBI regulations due to the issuance representing more than five percent of the post-issue fully diluted share capital. The final price was derived from three distinct benchmarks:

Metric Value (₹) Source/Regulation
90-day VWAP 154.48 Regulation 164(a)
10-day VWAP 195.98 Regulation 164(b)
Valuer Estimate 189.46 Corporate Professionals Valuation Services Pvt Ltd
Regulatory Floor 195.98 Higher of VWAP methods
Final Issue Price 196.00 Board Decision

An independent valuation report by Corporate Professionals Valuation Services Private Limited placed the warrant value at ₹189.46. However, SEBI Regulation 166A requires the minimum issue price to be the higher of the price determined under Regulation 164 or the valuation report. Consequently, the regulatory floor stood at ₹195.98.

What the Numbers Show

The board’s decision to set the issue price at ₹196 represents a premium of just ₹0.02 over the strict regulatory floor. This minimal margin suggests the company prioritized compliance efficiency and investor certainty over maximizing immediate capital raise per unit, likely to ensure swift allotment completion. The significant divergence between the 90-day average (₹154.48) and the 10-day average (₹195.98) indicates notable volatility in the stock’s trading price leading up to the relevant date, with recent trading activity driving the floor price significantly higher than longer-term trends.

All other particulars in the Explanatory Statement to the EGM Notice remain unchanged. The company is listed on the National Stock Exchange of India Limited and BSE Limited.

Historical Stock Returns for Ind Swift Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-4.49%-0.58%+55.69%+159.38%+247.03%+405.61%

How might the minimal ₹0.02 premium over the regulatory floor impact the short-term liquidity and trading volume of Ind-Swift Laboratories' warrants post-allotment?

Given the significant divergence between the 90-day and 10-day VWAP, what does this recent price volatility suggest about market sentiment and potential support levels for the stock?

What specific strategic initiatives or capital expenditures is Ind-Swift Laboratories planning to fund with the proceeds from this preferential allotment of warrants?

like16
dislike

More News on Ind Swift Laboratories

1 Year Returns:+247.03%